German pharmaceuticals and chemicals company Merck and Chinese internet firm Tencent have signed a memorandum of understanding on developing digital health services in China, Merck said Wednesday.
The aim is to improve information on health issues in the Chinese population and to facilitate treatment over the internet.
"We want to build on advanced internet platforms and artificial intelligence, big data, and cloud computing capabilities, and work with partners to make healthcare in China more convenient and efficient for all patients," Tencent Medical vice president Zhang Meng said.
Merck Biopharma China head Rogier Janssens said: "In this collaboration with Tencent, we will jointly explore the innovative combination of patient-centric healthcare management and digital platforms, which brings us one step closer to reaching our mission of transforming the lives of 40 million patients in China by 2025."
The companies aim to explore digital services that increase the awareness of allergy symptoms. In the area of infertility, the aim is to enhance awareness of disease and treatment options and help patients in need of resources to shorten the process of medical treatment.
Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.
A single purchase
